The positive effects of numerous H3R antagonists/inverse agonists in cognitive impairment, AD, PD, SCH, depression, anxiety, and sleep disorders are present in the literature and establish a promising stepping stone to address neuropathological features commonly occurring together. The gene discussed is HRH3; the disease is spindle cell hemangioma.